Estimating impossible curves using NONMEM

British Journal of Clinical Pharmacology

Volumn 42, Issue 3, 1996, Pages 283-290

  Schoemaker, Rik C ^a   Cohen, Adam F ^a  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

Low molecular weight heparin; NONMEM rising dose design; Parameter estimation

Indexed keywords

ANTIHYPERTENSIVE AGENT; DALTEPARIN; ENOXAPARIN;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; MATHEMATICAL MODEL; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TECHNIQUE; THEORY;

EID: 0029839379     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.04231.x     Document Type: Article

References (11)

1. van Boxtel CJ, Holford NHG, Danhof M (Eds.). The in vivo study of drug action. Elsevier, Amsterdam, 1992.
2. Peck CC, Barr WH, Benet LZ, et al. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Clin Pharmacol Ther 1992; 51: 465-473.
3. Danhof M, Peck CC (Eds.). Summary of 2nd international symposium on 'Measurement and kinetics of in vivo drug effects'. Leiden/Amsterdam Centre for Drug Research, Leiden, 1994.
4. Beal SL, Sheiner LB (Eds.). NONMEM Users Guides. NONMEM Project Group, University of California at San Francisco, San Francisco, 1992.
5. Lindstrom MJ, Bates DM. Nonlinear mixed effect models for repeated measures data. Biometrics 1990; 46: 673-687.
6. Sheiner LB, Ludden TM. Population pharmacokinetics/dynamics. Ann Rev Pharmacol Toxicol 1992; 32: 185-209.
7. Aarons L, Vozeh S, Wenk M, Weiss P, Follath F. Population pharmacokinetics of Tobramycin. Br J Clin Pharmacol 1989; 28: 305-314.
8. Kelman AW, Thomson AH, Whiting B, Bryson SM, Steedman DA, Mawer GE, Samba-Donga LA. Estimation of gentamycin clearance and volume of distribution in neonates and young children. Br J Clin Pharmacol 1984; 18: 685-692.
9. Yuh L, Beal S, Davidian M, et al. Population pharmacokinetic/pharmacodynamic methodology and applications: a bibliography. Biometrics 1994; 50: 566-575.
10. Stiekema JCJ, van Griensven JMT, van Dinther TG, Cohen AF. A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan. Br J Clin Pharmacol 1993; 36: 51-56.
11. Kroon C, de Boer A, Kroon JM, Schoemaker RC, Briet E, Cohen AF. Comparison of the bioavailability of heparin, Fragmin, Fraxiparine and Orgaran after subcutaneous administration in healthy volunteers. Br J Clin Pharmacol 1993; 35: 548P.